Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

GSKH vs. VEA: which is better?

Bottom line

GSKH vs VEA: the short answer

GSKH (GSK plc ADRhedged) and VEA (Vanguard Developed Markets Index Fund) are both etfs.

But VEA is far broader, holding 3,908 positions to 3 for GSKH, so beyond the top names it adds exposure GSKH doesn't have.

VEA is cheaper at 0.03% vs 0.19% — a difference of $16 a year per $10,000 invested.

Updated Nov 19, 2026

GSKH vs VEA side by side

GSKHVEA
TypeETFETF
Fund familyDWS (Xtrackers)Vanguard
CategoryInternational StockInternational Stock
Expense ratio0.19%0.03%
Annual cost per $10k$19$3
10-yr cost on $10k (prospectus)$243$39
Max front loadNoneNone
12b-1 fee0%0%
1-yr return—+35.2%
5-yr return (annualized)—+9.1%
10-yr return (annualized)—+8.7%
Best quarter—+17.5%
Worst quarter—−24.0%
Net assets (fund)$737.4K$316.4B
Number of holdings33,908
Portfolio turnover%4%
Returns as of—Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

GSKH and VEA share none of their top holdings.

GSKH top 10

  1. Gsk Plc — 96.79%
  2. Dreyfus Trsry Securities — 2.57%
  3. Canadian Imperial Bank Of Commerce — -0.19%

VEA top 10

  1. ASML Holding NV — 2.36%
  2. SK hynix Inc — 1.63%
  3. Samsung Electronics Co Ltd — 1.61%
  4. Samsung Electronics Co Ltd — 1.55%
  5. SK hynix Inc — 1.39%
  6. Vanguard Cmt Funds-Vanguard Market Liquidity Fund — 1.32%
  7. HSBC Holdings PLC — 1.00%
  8. Novartis AG — 0.90%
  9. Royal Bank of Canada — 0.90%
  10. Roche Holding AG — 0.89%

FAQ

What is the difference between GSKH and VEA?
GSKH (GSK plc ADRhedged) and VEA (Vanguard Developed Markets Index Fund) are both etfs. But VEA is far broader, holding 3,908 positions to 3 for GSKH, so beyond the top names it adds exposure GSKH doesn't have.
Which is cheaper, GSKH or VEA?
VEA has the lower expense ratio (0.03%).
Should I own both GSKH and VEA?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.